Younger founder Christin Glorioso on turning a six-month competition into a side-by-side trial of aging clocks.
Link as first comment.
@longevitytech.bsky.social
@longevitytech.bsky.socialYounger founder Christin Glorioso on turning a six-month competition into a side-by-side trial of aging clocks.
Link as first comment.
@karmactive.bsky.socialFollow @karmactive.bsky.social for more updates!
#Rentosertib #InsilicoMedicine #BiologicalAge #AgingClocks #IPF #AIDrugDiscovery #NatureBiotechnology #Longevity #ClinicalTrial #Biotech
@sprintome.bsky.socialNature Biotechnology reports integration of six proteomic aging clocks in a phase 2a trial for anti-aging assessment. This novel approach signifies a significant step towards personalized geroprotective interventions. #Research #AgingClocks